AI-READI Cohort
Cross-source consensus on AI-READI Cohort from 1 sources and 4 claims.
1 sources · 4 claims
Risks & contraindications
Where it comes from
Highlighted claims
- The secondary analysis included 1067 participants with assigned glycaemic status and MoCA data from the first public AI-READI release. — Association of diabetes severity with cognitive function in US adults: a cross-sectional analysis of the AI-READI multicentre cohort
- The analysis used data from the NIH-funded multicentre AI-READI study. — Association of diabetes severity with cognitive function in US adults: a cross-sectional analysis of the AI-READI multicentre cohort
- Participants were recruited from academic medical centres in Birmingham, San Diego, and Seattle. — Association of diabetes severity with cognitive function in US adults: a cross-sectional analysis of the AI-READI multicentre cohort
- The AI-READI public data release restricted some individual-level demographic and site identifiers to reduce reidentification and stigmatizing secondary-analysis risks. — Association of diabetes severity with cognitive function in US adults: a cross-sectional analysis of the AI-READI multicentre cohort